Clinical Research Directory
Browse clinical research sites, groups, and studies.
Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease
Sponsor: Tianjin Medical University
Summary
In the field of diagnosing Thrombi diseases, it is now a well established practice to inject positron-emitting tracers into the human body. These tracers bind to specific target proteins, allowing their distribution to be visualized via PET imaging. Currently, several research groups worldwide are engaged in developing and clinically validating their own GPIIb/IIIa imaging agents.
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2026-09-01
Completion Date
2031-09-01
Last Updated
2026-09-10
Healthy Volunteers
Yes
Conditions
Interventions
18F/68Ga-GP1
Each subject receive a single intravenous injection of 18F/68Ga-GP1, and undergo PET/ CT or MRI imaging within the specificed time.
Locations (3)
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, China
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China